Validation of Risk-Adapted Venous Thromboembolism Prediction in Multiple Myeloma Patients

Multiple myeloma (MM) is associated with an increased risk of venous thrombosis (VTE). In the United Kingdom Medical Research Council (MRC) XI study of patients treated with immunomodulatory therapy, the VTE rate was 11.8% despite 87.7% of the patients being on thromboprophylaxis at the time of thro...

Full description

Bibliographic Details
Main Authors: Aisling Barrett, John Quinn, Michelle Lavin, Patrick Thornton, James O’Donnell, Philip Murphy, Siobhán Glavey
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/16/3536